RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.

Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE

Open source

DOI
10.1038/sj.onc.1207272
Published
2004 Feb 26
Container
Oncogene
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/sj.onc.1207272,
  title = {RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.},
  author = {Duxbury MS and Ito H and Zinner MJ and Ashley SW and Whang EE},
  year = {2004},
  journal = {Oncogene},
  doi = {10.1038/sj.onc.1207272},
  url = {https://doi.org/10.1038/sj.onc.1207272}
}

RIS

TY  - JOUR
TI  - RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.
AU  - Duxbury MS
AU  - Ito H
AU  - Zinner MJ
AU  - Ashley SW
AU  - Whang EE
PY  - 2004
JO  - Oncogene
DO  - 10.1038/sj.onc.1207272
UR  - https://doi.org/10.1038/sj.onc.1207272
ER  - 

APA

MS, D., H, I., MJ, Z., SW, A., & EE, W. (2004). RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.. Oncogene. https://doi.org/10.1038/sj.onc.1207272

Source records